HF
MRVI icon

HRT Financial’s Maravai LifeSciences MRVI Stock Holding History

HRT Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Sell
76,283
-291,628
-79% -$989K ﹤0.01% 3153
2025
Q4 		$1.2M Buy
+367,911
New +$1.24M ﹤0.01% 1619
2025
Q2 		– Sell
-33,116
Closed -$73K – 3228
2025
Q1 		$73K Sell
33,116
-120,559
-78% -$476K ﹤0.01% 2199
2024
Q4 		$837K Buy
+153,675
New +$989K ﹤0.01% 1162
2024
Q2 		– Sell
-397,947
Closed -$3.45M – 2769
2024
Q1 		$3.45M Buy
397,947
+285,561
+254% +$1.93M 0.02% 375
2023
Q4 		$736K Buy
+112,386
New +$726K 0.01% 1148
2023
Q3 		– Sell
-96,365
Closed -$1.2M – 2835
2023
Q2 		$1.2M Buy
96,365
+78,619
+443% +$1.06M 0.01% 840
2023
Q1 		$248K Buy
+17,746
New +$255K ﹤0.01% 1827
2022
Q3 		– Sell
-9,176
Closed -$260K – 3248
2022
Q2 		$260K Sell
9,176
-33,371
-78% -$1.06M ﹤0.01% 2113
2022
Q1 		$1.5M Buy
+42,547
New +$1.43M 0.01% 781
2021
Q1 		– Sell
-305,395
Closed -$8.57M – 2981
2020
Q4 		$8.57M Buy
+305,395
New +$8.5M 0.17% 95

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's MRVI Position: Q1 2026 in Review

HRT Financial reduced its Maravai LifeSciences (MRVI) stake by 79% in Q1 2026, selling an estimated $989K and leaving 76,283 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #3153.

HRT Financial first reported a position in MRVI in Q4 2020 and has held it in 11 quarters since. The position peaked at $8.57M in Q4 2020. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • HRT Financial held 76,283 shares of Maravai LifeSciences worth $215K as of Q1 2026.
  • HRT Financial sold 291,628 Maravai LifeSciences shares in Q1 2026, an estimated $989K.
  • Maravai LifeSciences made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3153 holding.
  • HRT Financial first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 11 quarters since.
  • HRT Financial's Maravai LifeSciences position peaked at $8.57M in Q4 2020.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.